会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Folate-modified cholesterol-bearing pullulan as a drug carrier
    • 叶酸修饰的含胆固醇的支链淀粉作为药物载体
    • US20070042970A1
    • 2007-02-22
    • US11207888
    • 2005-08-22
    • Junzo SunamotoKazutoshi UshioMasaaki Hidaka
    • Junzo SunamotoKazutoshi UshioMasaaki Hidaka
    • A61K31/704A61K31/7076
    • A61K31/704A61K9/5161A61K31/7076A61K47/551A61K47/554A61K47/61
    • Folate modified cholesterol-bearing pullulan (FA-CHP) was synthesized by the reaction of folic acid γ-2-aminoethylamide and 4-nitorophenyl chloroformate-activated cholesterol-bearing pullulan, wherein folate and pullulan are connected through a NH—CH2—CH2—NH group. Approximately 0.5-1 folates are connected per about 100 glycoside units of pullulan. Then, several combinations of FA-CHP, cholesterol-bearing pullulan (CHP) and doxorubicin (DOX) mixture were tested for cancer selective cytotoxicity. A mixture of FA-CHP, CHP and DOX of 1:4:0.02 (weight ratio) gave sharp and selective damage to cells of a human epidermoid cancer KB known as expressing a high level of folate receptor. The same mixture inhibited the growth of HuH7 cells, which is a human hepatocellular carcinoma and is unknown as a folate receptor.
    • 叶酸修饰的含胆固醇的支链淀粉(FA-CHP)通过叶酸γ-2-氨基乙酰胺和4-硝苯基氯甲酸酯活化的含胆固醇的支链淀粉的反应合成,其中叶酸和支链淀粉通过NH-CH 2个-CH 2 -NH基。 每个约100个糖基单位的支链淀粉连接约0.5-1个叶酸盐。 然后,测试FA-CHP,含胆固醇的支链淀粉(CHP)和多柔比星(DOX)混合物的几种组合的癌症选择性细胞毒性。 1:4:0.02(重量比)的FA-CHP,CHP和DOX的混合物对称为表达高水平叶酸受体的人表皮样癌细胞的细胞产生明显和选择性的损伤。 相同的混合物抑制HuH7细胞的生长,HuH7细胞是人类肝细胞癌,并且作为叶酸受体是未知的。